Arondite | $12,000,000 | (May 2, 2025)
SafeHeal | $39,548,022 | (May 2, 2025)
Ceto | $4,800,000 | (May 2, 2025)
Certified by Founder
Lodge
NETRIS Pharma
start up
France
- Lyon, Rhône-Alpes
- 20/12/2023
- Series A
- $8,223,000
Our collaborators and partners are driven by a desire to contribute to the development of new ways of fighting cancer. The therapies developed by NETRIS Pharma are based on cellular mechanisms identified by a world-renowned research group.
Located in Léon Bérard Cancer Center (Lyon, France), NETRIS Pharma is a unique model of a biotechnology company integrated within a comprehensive cancer center.
- Industry Pharmaceutical Manufacturing
- Website https://www.netrispharma.com/
- LinkedIn https://www.linkedin.com/company/netris-pharma/about/
Gruve | $20,000,000 | (May 2, 2025)
Peek(US) | $5,000,000 | (May 2, 2025)
Paramark.com | $8,000,000 | (May 2, 2025)
Zoe Financial | $30,000,000 | (May 2, 2025)
Hoofprint Biome | $15,000,000 | (May 2, 2025)
Stately Bio | $12,000,000 | (May 2, 2025)
SatLeo Labs | $3,300,000 | (May 2, 2025)
QbDVision | $13,000,000 | (May 2, 2025)
Blacksmith | $3,500,000 | (May 2, 2025)